Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,294,705
+$277,486 QoQ
Shares Held
9,119
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,862
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ironwood Investment Counsel, LLC holds $31,349,950 across 7 Drug Manufacturers - General names. ABBV ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,795 | $16,202,016 | |
| 2 | AMGN |
Amgen Inc
|
20,809 | $7,535,355 | |
| 3 | LLY |
ELI LILLY & Co
|
3,573 | $4,285,563 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,119 | $2,294,705 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,171 | $400,624 | |
| 6 | PFE |
Pfizer Inc
|
15,465 | $372,397 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,500 | $259,290 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,294,705 | 9,119 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,017,219 | 9,275 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,146,206 | 9,393 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,662,246 | 11,498 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,221,871 | 11,970 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,082,628 | 9,940 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,751,411 | 9,856 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,954,459 | 9,897 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,686,213 | 9,831 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,831,561 | 10,058 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,614,012 | 10,415 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,587,936 | 10,653 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $853,245 | 6,333 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,157,823 | 7,265 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,233,730 | 7,634 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,053,951 | 7,853 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,303,697 | 8,512 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,541,828 | 9,511 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,312,026 | 9,690 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,049,467 | 9,729 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,064,673 | 9,452 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,030,470 | 9,522 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,438,167 | 13,422 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $942,118 | 10,756 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,066,332 | 10,861 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $758,395 | 9,954 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||